报价延迟最少15分钟:2025/11/28 03:05 EST
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.63 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-8.60/--
|
|
企业价值
85.78M
|
| 资产负债 |
|
每股账面净值
-10.93
|
| 现金流量 |
|
现金流量率
0.52
|
| 损益表 |
|
收益
14.40B
|
|
每股收益
233.35
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| 111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment. |
